The DOI matches its Crossref record; 37 of the 39 references it cites were found in a registry or an index.
Presence of hypochlorite-modified proteins in human atherosclerotic lesions.
Open accessAbstract
Oxidation of LDL may contribute to atherogenesis, though the nature of the in vivo oxidant(s) remains obscure. Myeloperoxidase, the enzyme responsible for hypochlorous acid/hypochlorite (HOCl) production in vivo, is present in active form in human atherosclerotic lesions, and HOCl aggregates and transforms LDL into a high-uptake form for macrophages in vitro. Here we demonstrate HOCl-modified proteins in human lesions using an mAb raised against HOCl-modified LDL that recognizes HOCl-oxidized proteins but does not cross-react with Cu2+-, malondialdehyde-, or 4-hydroxynonenal-modified LDL. This antibody detected significantly more material in advanced atherosclerotic lesions than normal arteries, even though azide and methionine were included during sample work-up to inhibit myeloperoxidase and to scavenge HOCl. The epitope(s) recognized was predominantly cell associated and present in monocyte/macrophages, smooth muscle, and endothelial cells. The intima and cholesterol clefts stained more heavily than the center of the thickened vessels; adventitial staining was apparent in some cases. Immunostaining was also detected in a very early lesion from an accident victim, beside healthy areas that were unreactive. LDL oxidized by HOCl in vitro, but not native LDL, effectively competed with the epitopes in lesions for antibody binding. Density centrifugation of plaque homogenates and Western blot analysis showed that, in the apo B-containing lipoprotein fraction, the mAb recognized protein(s) of molecular mass greater than apo B, similar to those produced during oxidation of LDL with HOCl in vitro. Three major proteins were recognized by the anti-HOCl-modified protein antibody but not by an anti-apo B antibody in the apo B-free fraction. Together, these results demonstrate HOCl-oxidized proteins in human atherosclerotic lesions, implicating this oxidant in LDL modification in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Macrophage localization in the atherosclerotic plaque leads to detectable MPO activity and products of HOCl oxidation (213, 414).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [414]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measurement of protein using bicinchoninic acid
Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., & Klenk, D. C. (1985) · Analytical Biochemistry · doi:10.1016/0003-2697(85)90442-7 · Cited by 18,482
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,618
Theory and Practice of Histological Techniques
Bancroft, J. D., & Gamble, M. (1990) · Cited by 6,948
Epstein, F. H., Steinberg, D. I., Parthasarathy, S., Carew, T. E., Khoo, J. C., & Witztum, J. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201407 · Cited by 6,425
Ylä‐Herttuala, S., Palinski, W., Rosenfeld, M. E., Parthasarathy, S., Carew, T. E., Butler, S. S., Witztum, J. L., & Steinberg, D. H. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114271 · Cited by 1,877
Low density lipoprotein undergoes oxidative modification in vivo.
Palinski, W., Rosenfeld, M. E., Ylä‐Herttuala, S., Gurtner, G. C., Socher, S. S., Butler, S. W., Parthasarathy, S., Carew, T. E., Steinberg, D. H., & Witztum, J. L. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.4.1372 · Cited by 1,514
Rg, G. (1981) · PubMed Central · Cited by 1,314
Stary, H. C., Chandler, A. B., Glagov, S. K., Guyton, J. R., Insull, W., Rosenfeld, M. E., Schaffer, S. A., Schwartz, C. J., Wagner, W. D., & Wissler, R. W. (1994) · Circulation · doi:10.1161/01.cir.89.5.2462 · Cited by 1,313
Autoantibody against oxidised LDL and progression of carotid atherosclerosis
Salonen, J. T., Korpela, H., Salonen, R., Nyyssönen, K., Ylä‐Herttuala, S., Yamamoto, R., Butler, S., Palinski, W., & Witztum, J. L. (1992) · The Lancet · doi:10.1016/0140-6736(92)90926-t · Cited by 1,311
Daugherty, A., Dunn, J. L., Rateri, D. L., & Heinecke, J. W. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117342 · Cited by 1,269
Flagged first, then by citations
2 of the 39 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Adams, D.O., and T.A. Hamilton. 1992. Macrophages as destructive cells in host defense. In Inflammation: Basic principles and clinical correlates. J.I. Gallin, I.M. Goldstein, and R. Snyderman. Raven Press, New York. 637- 662.
Cited by
Sorted by citations
Items 101–200 of 593
Chang, C., Wang, F., Qiang, J., Zhang, Z., Chen, Y., Zhang, W., Wang, Y., & Chen, X. (2016) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2016.11.123 · Cited by 146
The role of vitamin E in atherosclerosis
Upston, J. M., Kritharides, L., & Stocker, R. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00024-9 · Cited by 147
Self-citationUncoupling of Endothelial Nitric Oxidase Synthase by Hypochlorous Acid
Xu, J., Xie, Z., Reece, R., Pimental, D. R., & Zou, M. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000249394.94588.82 · Cited by 146
RetractedBrown, K. E., Brunt, E. M., & Heinecke, J. W. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63059-3 · Cited by 141
Immunohistochemical and ELISA Assays for Biomarkers of Oxidative Stress in Aging and Diseasea
Onorato, J. M., Thorpe, S. R., & Baynes, J. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb09909.x · Cited by 141
Pattison, D. I., Hawkins, C. L., & Davies, M. J. (2003) · Chemical Research in Toxicology · doi:10.1021/tx025670s · Cited by 139
Thomas, S. R., Leichtweis, S. B., Pettersson, K. S., Croft, K. D., Mori, T. A., Brown, A. J., & Stocker, R. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.4.585 · Cited by 138
Self-citationNagai, R., Hayashi, C. M., Xia, L., Takeya, M., & Horiuchi, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205688200 · Cited by 136
Mass Spectrometric Quantification of 3-Chlorotyrosine in Human Tissues with Attomole Sensitivity
Hazen, S. L., Crowley, J. R., Mueller, D. M., & Heinecke, J. W. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(97)00084-1 · Cited by 134
Duan, Q., Jia, P., Zhuang, Z., Liu, C., Zhang, X., Wang, Z., Sheng, W., Li, Z., Zhu, H., Zhu, B., et al. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b04726 · Cited by 131
Yang, J. J., Preston, G. A., Pendergraft, W. F., Segelmark, M., Heeringa, P., Hogan, S. L., Jennette, J. C., & Falk, R. J. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64000-x · Cited by 131
Human myeloperoxidase: A potential target for molecular MR imaging in atherosclerosis
Chen, J. W., Pham, W. N., Weissleder, R., & Bogdanov, A. A., Jr. (2004) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20270 · Cited by 130
Wang, W.-K., Zhang, L., Li, L., & Tian, Y. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.6b02081 · Cited by 129
Immunological evidence for hypochlorite-modified proteins in human kidney.
Malle, E., Woenckhaus, C., Waeg, G., Esterbauer, H., Gröne, E. F., & Gröne, H. (1997) · Europe PMC (PubMed Central) · Cited by 127
Self-citationActions of “antioxidants” in the protection against atherosclerosis
Lönn, M. E., Dennis, J. M., & Stocker, R. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.05.027 · Cited by 124
Self-citationMeasuring chlorine bleach in biology and medicine
Kettle, A. J., Albrett, A. M., Chapman, A., Dickerhof, N., Forbes, L. V., Khalilova, I. S., & Turner, R. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.07.004 · Cited by 123
Bergt, C., Fu, X., Saifee, N. H., Kao, J. L.-F., & Heinecke, J. W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309046200 · Cited by 123
Cheng, D., Talib, J., Stanley, C. P., Rashid, I., Michaëlsson, E., Lindstedt, E., Croft, K. D., Kettle, A. J., Maghzal, G. J., & Stocker, R. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.312725 · Cited by 120
Self-citationOxidation Regulates the Inflammatory Properties of the Murine S100 Protein S100A8
Harrison, C. A., Raftery, M. J., Walsh, J., Alewood, P. F., Iismaa, S. E., Thliveris, S., & Geczy, C. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8561 · Cited by 123
NADPH oxidase-derived oxidant stress is critical for neutrophil cytotoxicity during endotoxemia
Gujral, J. S., Hinson, J., Farhood, A. I., & Jaeschke, H. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00287.2003 · Cited by 123
Evolving Concepts of Oxidative Stress and Reactive Oxygen Species in Cardiovascular Disease
Chen, K., & Keaney, J. F. (2012) · Current Atherosclerosis Reports · doi:10.1007/s11883-012-0266-8 · Cited by 122
Matthijsen, R. A., Huugen, D., Hoebers, N., de Vries, B., Peutz‐Kootstra, C. J., Aratani, Y., Daha, M. R., Tervaert, J. W. C., Buurman, W. A., & Heeringa, P. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.070184 · Cited by 120
Davies, M. J. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107685 · Cited by 119
Ma, H., Song, B., Wang, Y., Cong, D., Jiang, Y., & Yuan, J. (2016) · Chemical Science · doi:10.1039/c6sc02243j · Cited by 119
The Mystery of Diabetes and Atherosclerosis: Time for a New Plot
Semenkovich, C. F., & Heinecke, J. W. (1997) · Diabetes · doi:10.2337/diab.46.3.327 · Cited by 119
Rensen, S. S., Bieghs, V., Xanthoulea, S., Arfianti, E., Bakker, J. A., Shiri-Sverdlov, R., Hofker, M. H., Greve, J. W., & Buurman, W. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052411 · Cited by 116
Shen, Y., Croft, K. D., Hodgson, J. M., Kyle, R. A., Lee, I.-L. E., Wang, Y., Stocker, R., & Ward, N. C. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.07.016 · Cited by 118
Self-citationHeinecke, J. W. (2002) · Toxicology · doi:10.1016/s0300-483x(02)00192-0 · Cited by 116
Marsche, G., Hammer, A., Oskolkova, O., Kozarsky, K., Sattler, W., & Malle, E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200503200 · Cited by 116
Self-citationDoes an acidic pH explain why low density lipoprotein is oxidised in atherosclerotic lesions?
Leake, D. S. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(96)06035-2 · Cited by 116
The Biological Chemistry of Peroxynitrite
Radí, R., Denicola, A., Álvarez, B., Ferrer‐Sueta, G., & Rubbo, H. (2000) · Elsevier eBooks · doi:10.1016/b978-012370420-7/50005-8 · Cited by 115
Are advanced oxidation protein products potential uremic toxins?
Witko‐Sarsat, V., Gausson, V., & Descamps‐Latscha, B. (2003) · Kidney International · doi:10.1046/j.1523-1755.63.s84.47.x · Cited by 114
Shao, B., Fu, X., McDonald, T. O., Green, P. S., Uchida, K., O’Brien, K. D., Oram, J. F., & Heinecke, J. W. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508169200 · Cited by 114
High density lipoprotein oxidation: in vitro susceptibility and potential in vivo consequences
Francis, G. A. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(99)00181-x · Cited by 114
Woods, A. A., Linton, S. M., & Davies, M. J. (2003) · Biochemical Journal · doi:10.1042/bj20021710 · Cited by 111
Ursini, F., & Sevanian, A. (2002) · Biological Chemistry · doi:10.1515/bc.2002.062 · Cited by 110
Pathways of phospholipid oxidation by HOCl in human LDL detected by LC-MS
Jerlich, A., Pitt, A. R., Schaur, R. J., & Spickett, C. M. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00273-7 · Cited by 110
Enhanced Fluorescence Turn‐on Imaging of Hypochlorous Acid in Living Immune and Cancer Cells
Mulay, S. V., Choi, M., Jang, Y. J., Kim, Y., Jon, S., & Churchill, D. G. (2016) · Chemistry - A European Journal · doi:10.1002/chem.201601270 · Cited by 107
Huang, Y., Zhang, Y., Huo, F., Chao, J., & Yin, C. (2019) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2019.02.075 · Cited by 108
Marsche, G., Heller, R., Fauler, G., Kovacevic, A., Nuszkowski, A., Graier, W. F., Sattler, W., & Malle, E. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000148703.43429.25 · Cited by 108
Self-citationHazell, L. J., Davies, M. J., & Stocker, R. (1999) · Biochemical Journal · doi:10.1042/bj3390489 · Cited by 108
Self-citationLow-Density Lipoprotein Modified by Myeloperoxidase in Inflammatory Pathways and Clinical Studies
Delporte, C., Antwerpen, P. V., Vanhamme, L., Roumeguère, T., & Boudjeltia, K. Z. (2013) · Mediators of Inflammation · doi:10.1155/2013/971579 · Cited by 109
Nuszkowski, A., Gräbner, R., Marsche, G., Unbehaun, A., Malle, E., & Heller, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007659200 · Cited by 106
Self-citationNiu, X., Zammit, V. C., Upston, J. M., Dean, R. T., & Stocker, R. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.7.1708 · Cited by 105
Self-citationHydrogen sulphide: A novel physiological inhibitor of LDL atherogenic modification by HOCl
Laggner, H., Muellner, M. K., Schreier, S. M., Sturm, B., Hermann, M., Exner, M., Laggner, H., Muellner, M. K., Schreier, S. M., Sturm, B., et al. (2007) · Free Radical Research · doi:10.1080/10715760701263265 · Cited by 103
Myeloperoxidase: Growing importance in cancer pathogenesis and potential drug target
Valadez-Cosmes, P., Raftopoulou, S., Mihalič, Z. N., Marsche, G., & Kargl, J. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.108052 · Cited by 108
Anti-atherogenic effect of coenzyme Q10 in apolipoprotein E gene knockout mice
Witting, P. K., Pettersson, K. S., Letters, J., & Stocker, R. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00311-7 · Cited by 104
Self-citationKumar, A. P., Piedrafita, F. J., & Reynolds, W. F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311625200 · Cited by 102
Carr, A. C., TIJERINA, T., & Frei, B. B. (2000) · Biochemical Journal · doi:10.1042/bj3460491 · Cited by 103
Myeloperoxidase binds to low‐density lipoprotein: potential implications for atherosclerosis
Carr, A. C., Myzak, M. C., Stocker, R., McCall, M. R., & Frei, B. B. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02227-4 · Cited by 102
Self-citationFu, S., Wang, H., Davies, M. J., & Dean, R. T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.10851 · Cited by 103
REES, M. D., HAWKINS, C. L., & DAVIES, M. J. (2004) · Biochemical Journal · doi:10.1042/bj20040148 · Cited by 100
Panzenboeck, U., Raitmayer, S., Reicher, H., Lindner, H., Glatter, O., Malle, E., & Sattler, W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.47.29711 · Cited by 100
Self-citationAdenosine Monophosphate (AMP)-Activated Protein Kinase: A New Target for Nutraceutical Compounds
Marín‐Aguilar, F., Pavillard, L. E., Giampieri, F., Bullón, P., & Cordero, M. D. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020288 · Cited by 103
Jiang, R., Hodgson, J. M., Mas, E., Croft, K. D., & Ward, N. C. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.08.017 · Cited by 100
Wang, B., Chen, D., Srinivasulu, K., Wang, F., Wang, Y., Zhang, W., Yin, J., Chen, H., & Chen, X. (2015) · Dyes and Pigments · doi:10.1016/j.dyepig.2015.03.022 · Cited by 97
Growing Significance of Myeloperoxidase in Non-infectious Diseases
Hoy, A., Leininger‐Muller, B., Kutter, D., Siest, G., & Visvikis‐Siest, S. (2002) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2002.002 · Cited by 96
Yu, S.-Y., Hsu, C.-Y., Chen, W.-C., Wei, L.-F., & Wu, S. (2014) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2014.01.121 · Cited by 95
Rees, M. D., Hawkins, C. L., & Davies, M. J. (2003) · Journal of the American Chemical Society · doi:10.1021/ja0370591 · Cited by 95
Myeloperoxidase Inhibitors as Potential Drugs
Pašti, T. D. L., Leskovac, A. R., & Vasić, V. (2015) · Current Drug Metabolism · doi:10.2174/138920021603150812120640 · Cited by 95
Heinecke, J. W., Hsu, F., Crowley, J. R., Hazen, S. L., Leeuwenburgh, C., Mueller, D. M., RASMUSSEN, J. E., & TURK, J. W. (1999) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(99)00121-4 · Cited by 94
Statins downregulate myeloperoxidase gene expression in macrophages
Kumar, A. P., & Reynolds, W. F. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.204 · Cited by 94
Oxidative Stress and Endothelial Nitric Oxide Bioactivity
Thomas, S. R., Chen, K., & Keaney, J. F. (2003) · Antioxidants and Redox Signaling · doi:10.1089/152308603764816541 · Cited by 93
Malle, E., Marsche, G., Panzenboeck, U., & Sattler, W. (2005) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2005.08.008 · Cited by 92
Self-citationVitamin E Oxidation in Human Atherosclerotic Lesions
Terentis, A. C., Thomas, S. R., Burr, J. A., Liebler, D. C., & Stocker, R. (2002) · Circulation Research · doi:10.1161/hh0302.104454 · Cited by 93
Self-citationReaction between protein radicals and other biomolecules
Østdal, H., Davies, M. J., & Andersen, H. J. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00785-2 · Cited by 91
Hypothiocyanous Acid: Benign or Deadly?
Barrett, T. J., & Hawkins, C. L. (2011) · Chemical Research in Toxicology · doi:10.1021/tx200219s · Cited by 91
Site-Specific Antiatherogenic Effect of Probucol in Apolipoprotein E–Deficient Mice
Witting, P. K., Pettersson, K. S., Letters, J., & Stocker, R. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.8.e26 · Cited by 92
Self-citationLi, J., Yang, X., Zhang, D., Liu, Y., Tang, J., Li, Y., Zhao, Y., & Ye, Y. (2018) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2018.03.027 · Cited by 87
The Enzymatic and Non-Enzymatic Function of Myeloperoxidase (MPO) in Inflammatory Communication
Kargapolova, Y., Geißen, S., Zheng, R., Baldus, S. E., Winkels, H., & Adam, M. (2021) · Antioxidants · doi:10.3390/antiox10040562 · Cited by 93
Lipid oxidation by hypochlorous acid: chlorinated lipids in atherosclerosis and myocardial ischemia
Ford, D. A. (2010) · Clinical Lipidology · doi:10.2217/clp.10.68 · Cited by 83
Low-density lipoprotein and its effect on human blood platelets
Relou, I. A. M., Hackeng, C. M., Akkerman, J. N., & Malle, E. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-2249-y · Cited by 84
Self-citationNeutrophil myeloperoxidase revisited: it's role in health and disease
Deby-Dupont, G. P., Deby, C. M. T., & Lamy, M. (1999) · Intensivmedizin und Notfallmedizin · doi:10.1007/s003900050270 · Cited by 84
Stocker, R., Huang, A., Jeranian, E., Hou, J. Y., Wu, T. T., Thomas, S. R., & Keaney, J. F. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000143388.20994.fa · Cited by 84
Self-citationNybo, T., Dieterich, S., Gamon, L. F., Chuang, C. Y., Hammer, A., Höefler, G., Malle, E., Rogowska-Wrzesińska, A., & Davies, M. J. (2018) · Redox Biology · doi:10.1016/j.redox.2018.10.022 · Cited by 81
Self-citationHazen, S. L., Gaut, J. P., Hsu, F., Crowley, J. R., d'Avignon, A., & Heinecke, J. W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.27.16990 · Cited by 83
A turn-on fluorescent probe for hypochlorous acid based on the oxidation of diphenyl telluride
Venkatesan, P., & Wu, S. (2014) · The Analyst · doi:10.1039/c4an02116a · Cited by 82
The role of hypothiocyanous acid (HOSCN) in biological systems
Hawkins, C. L. (2009) · Free Radical Research · doi:10.3109/10715760903214462 · Cited by 81
Pleiotropic Roles of S100A12 in Coronary Atherosclerotic Plaque Formation and Rupture
Goyette, J., Yan, W. X., Yamen, E., Chung, Y. M., Lim, S. Y., Hsu, K., Rahimi, F., Girolamo, N. D., Song, C., Jessup, W., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900373 · Cited by 79
Lipoprotein oxidation in cardiovascular disease: chief culprit or innocent bystander?
Heinecke, J. W. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060218 · Cited by 79
Insights into myeloperoxidase biosynthesis from its inherited deficiency
Nauseef, W. M. (1998) · Journal of Molecular Medicine · doi:10.1007/s001090050265 · Cited by 79
The impact of sterile inflammation in acute liver injury
Woolbright, B. L. (2017) · Journal of Clinical and Translational Research · doi:10.18053/jctres.03.2017s1.003 · Cited by 79
Heinecke, J. W. (1997) · BioFactors · doi:10.1002/biof.5520060208 · Cited by 78
Zhang, W., Guo, C., Liu, L., Qin, J., & Yang, C. (2011) · Organic & Biomolecular Chemistry · doi:10.1039/c1ob05550j · Cited by 77
Hazell, L., Baernthaler, G., & Stocker, R. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00717-1 · Cited by 78
Self-citationChen, W.-C., Venkatesan, P., & Wu, S. (2015) · Analytica Chimica Acta · doi:10.1016/j.aca.2015.04.012 · Cited by 77
Hazell, L. J., & Stocker, R. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01066-1 · Cited by 77
Self-citationClinical significance of the humoral immune response to modified LDL
Lopes-Virella, M. F., & Virella, G. (2009) · Clinical Immunology · doi:10.1016/j.clim.2009.04.001 · Cited by 76
Shangguan, M., Jiang, X., Lu, Z., Zou, W., Chen, Y., Xu, P., Pan, Y.-J., & Hou, L. (2019) · Talanta · doi:10.1016/j.talanta.2019.04.074 · Cited by 76
Maiocchi, S. L., Ku, J., Thai, T., Chan, E., Rees, M. D., & Thomas, S. R. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107711 · Cited by 78
Morgan, P. E., Pattison, D. I., Talib, J., Summers, F. A., Harmer, J. A., Celermajer, D. S., Hawkins, C. L., & Davies, M. J. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.08.008 · Cited by 76
Betanin inhibits the myeloperoxidase/nitrite-induced oxidation of human low-density lipoproteins
Allegra, M., Tesoriere, L., & Livrea, M. A. (2007) · Free Radical Research · doi:10.1080/10715760601038783 · Cited by 76
Modification of proteins and lipids by myeloperoxidase
Hazen, S. L., Hsu, F., Gaut, J. P., Crowley, J. R., & Heinecke, J. W. (1999) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(99)00117-2 · Cited by 76
Kopprasch, S., Leonhardt, W., Pietzsch, J., & Kühne, H. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(97)00233-5 · Cited by 75
Sirpal, S. (2009) · Clinical Science · doi:10.1042/cs20080322 · Cited by 74
Hammer, A., Desoyé, G., Dohr, G., Sattler, W., & Malle, E. (2001) · Laboratory Investigation · doi:10.1038/labinvest.3780263 · Cited by 74
Self-citationDelporte, C., Boudjeltia, K. Z., Noyon, C., Furtmüller, P. G., Nuyens, V., Slomianny, M., Madhoun, P., Desmet, J.-M., Raynal, P., Dufour, D., et al. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m047449 · Cited by 74
Self-citationHypochlorous acid turn-on boron dipyrromethene probe based on oxidation of methyl phenyl sulfide
Liu, S.-R., Vedamalai, M., & Wu, S. (2013) · Analytica Chimica Acta · doi:10.1016/j.aca.2013.09.018 · Cited by 73
Yang, C.-Y., Gu, Z., Yang, M., Lin, S., Garcia‐Prats, A. J., Rogers, L. K., Welty, S. E., & Smith, C. V. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32148-9 · Cited by 73
Gröne, H., Gröne, E. F., & Malle, E. (2002) · Laboratory Investigation · doi:10.1038/labinvest.3780390 · Cited by 72
Self-citation
Metadata
- Authors
- Hazell, L. J., Arnold, L., Flowers, D., Waeg, G., Malle, E., & Stocker, R.
- Affiliations
- The Heart Research Institute (AU)
- The University of Sydney (AU)
- University of Graz (AT)
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 1996-03-15
- Volume
- 97
- Issue
- 6
- Pages
- 1535-1544
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC507214
- OpenAlex
- W2118480498
- Cited by
- 592
- References
- 39
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 14 · 2023: 14 · 2022: 19 · 2021: 12 · 2020: 18 · 2019: 20 · 2018: 26 · 2017: 16 · 2016: 12 · 2015: 17 · 2014: 15 · 2013: 13 · 2012: 16
- FWCI
- 11.70
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart Foundation of Australia
- Austrian Science Fund
- Medical Research Council
- National Health and Medical Research Council
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Keywords
- hypochlorite, myeloperoxidase, atherosclerosis, LDL oxidation, oxidized LDL, atherosclerotic plaque, macrophages, smooth muscle cells, endothelial cells, oxidizing agents, atherogenesis
- MeSH terms
- Arteriosclerosis, Humans, Hypochlorous Acid, Immunohistochemistry, Lipoproteins, LDL, Oxidation-Reduction, Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review